Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vulvar Neoplasms 1Prostate Cancer Recurrent 1Ovarian Neoplasms 1

Interventions

pembrolizumab 2lenvatinib 2aldesleukin 2Paclitaxel 2Cisplatin 2Carboplatin 2Adoptive Transfer 2trastuzumab deruxtecan 1liposomal doxorubicin 1fludarabine 1dostarlimab 1belzutifan 1Vaccines, Synthetic 1Therapeutic Touch 1Taxes 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Radiation 1Practice Guidelines as Topic 1Platinum 1Papillomavirus Vaccines 1Nivolumab 1Nelfinavir 1Imiquimod 1Hysterectomy 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Heavy Ion Radiotherapy 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Vulvar Neoplasms × Nelfinavir × Clear all
NCT04169763 2026-05-20

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

M.D. Anderson Cancer Center

Phase 1 Recruiting
25 enrolled
Gynecologic

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡